U.S. stock insider trading | Integra Life Sciences disclosed 11 insider trading transactions on March 12

K-LinePoet · 2026-04-09T21:55:51+00:00

Integra Life Sciences (IART) disclosed multiple insider trades on March 12, 2026. Executives such as DAVIS ROBERT T. JR. sold a large number of shares between March 10 and March 11, with the total amount reaching tens of hundreds of thousands of US dollars. The company focuses on medical technology and innovative therapies to improve patient outcomes.

K-LinePoet

2026-04-09 21:55:51

Abstract generation in progress

On March 12, 2026, Integra Lifesciences (IART) disclosed 11 insider trading transactions. Executive DAVIS ROBERT T. JR. sold 8,487 shares on March 11, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 12, 2026	Executive	Singh Harvinder	March 10, 2026	Sell	601	9.55	5,739.55
March 12, 2026	Executive	DAVIS ROBERT T. JR.	March 11, 2026	Sell	8,487	9.61	$81.6k
March 12, 2026	Executive	McBreen Michael J.	March 11, 2026	Sell	7,247	9.61	$69.6k
March 12, 2026	Executive	McBreen Michael J.	March 10, 2026	Sell	2,354	9.55	$22.5k
March 12, 2026	Executive	Singh Harvinder	March 11, 2026	Sell	6,051	9.61	$58.2k
March 12, 2026	Executive	DAVIS ROBERT T. JR.	March 10, 2026	Sell	687	9.55	$6,560.85
March 12, 2026	Executive	Veillon-Berteloot Chantal	March 11, 2026	Sell	5,420	9.61	$52.1k
March 12, 2026	Executive	Knight Lea Daniels	March 11, 2026	Sell	8,089	9.61	$77.7k
March 12, 2026	Executive	Mosebrook Jeffrey	March 11, 2026	Sell	806	9.61	$7,745.66
March 12, 2026	Executive	Mosebrook Jeffrey	March 10, 2026	Sell	341	9.55	$3,256.55

【Company Profile】

Integra Lifesciences Holdings Corporation was incorporated in Delaware in 1989. It is a global leading medical technology company that improves patient outcomes through innovative treatment approaches and sets new standards in surgery, neurology, and regenerative care. The company expands its regenerative technology business through global acquisitions and product development, including surgical instruments, neurosurgical products, and advanced wound care, to meet the evolving needs of customers and enhance patient care.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes